FMP
Vigil Neuroscience, Inc.
VIGL
NASDAQ
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.
2.82 USD
0.07 (2.48%)
About
ceo
Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.vigilneuro.com
exchange
NASDAQ
Description
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative disea...
CIK
0001827087
ISIN
US92673K1088
CUSIP
92673K108
Address
1 Broadway
Phone
857 254 4445
Country
US
Employee
69
IPO Date
Jan 7, 2022
Summary
CIK
0001827087
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
92673K108
ISIN
US92673K1088
Country
US
Price
2.82
Beta
1.78
Volume Avg.
89.29k
Market Cap
104.01M
Shares
-
52-Week
2.53-11.11
DCF
0.99
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.32
P/B
-
Website
https://www.vigilneuro.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest VIGL News
It looks like there's no news available.
